Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
545.5 INR | +2.86% | +2.05% | +65.10% |
04-18 | Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US | MT |
04-17 | Shilpa Medicare Gets GMP Certification from Austrian Agency for Telangana, India Unit | MT |
Sales 2022 | 11.47B 138M 11.01B | Sales 2023 | 10.52B 126M 10.1B | Capitalization | 19.91B 239M 19.11B |
---|---|---|---|---|---|
Net income 2022 | 607M 7.28M 583M | Net income 2023 | -325M -3.9M -312M | EV / Sales 2022 | 3.58 x |
Net Debt 2022 | 6.58B 78.91M 6.32B | Net Debt 2023 | 7.79B 93.44M 7.48B | EV / Sales 2023 | 2.63 x |
P/E ratio 2022 |
54.7
x | P/E ratio 2023 |
-61.3
x | Employees | 1,179 |
Yield 2022 |
0.28% | Yield 2023 |
-
| Free-Float | 39.28% |
Latest transcript on Shilpa Medicare Limited
1 day | +2.86% | ||
1 week | +2.05% | ||
Current month | +18.24% | ||
1 month | +20.18% | ||
3 months | +64.80% | ||
6 months | +61.13% | ||
Current year | +65.10% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 19/11/87 | |
Alpesh Dalal
DFI | Director of Finance/CFO | - | 30/05/21 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 19/11/87 | |
Director/Board Member | 58 | 01/09/21 | |
Arvind Vasudeva
BRD | Director/Board Member | 63 | 01/09/21 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 117 M€ | +1.11% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 545.5 | +2.86% | 27,032 |
25/04/24 | 530.4 | -0.15% | 20,984 |
24/04/24 | 531.2 | -0.75% | 33,635 |
23/04/24 | 535.2 | -0.12% | 14,922 |
22/04/24 | 535.8 | +0.23% | 44,761 |
Delayed Quote Bombay S.E., April 26, 2024 at 11:00 am
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+65.10% | 568M | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- SHILPAMED Stock